Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Continuation Study Of PF-3512676 (CPG 7909) Injection In Patients With Metastatic Or Recurrent Malignancies Who Have Stable Disease Or Who Have Responded To Pf-3512676 Injection Therapy

NCT00043368 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00043368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00043368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Continuation Study Of PF-3512676 (CPG 7909) Injection In Patients With Metastatic Or Recurrent Malignancies Who Have Stable Disease Or Who Have Responded To Pf-3512676 Injection Therapy
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2002
Completion date
June 30, 2007
Enrollment
31 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms, carcinoma, non-small-cell lung, carcinoma, renal cell, lymphoma, t-cell, melanoma